TMCI:NASDAQ
Treace Medical Concepts, Inc
$5.27
arrow_downward
-1.31%(-0.070) 1D
$5.30
arrow_upward
+0.57% (+0.030)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$5.32
High
$5.32
Low
$4.95
Mkt. cap
345.50M
Avg. vol.
294.14K
Volume
287.80K
52-wk high
$5.44
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
Open
$5.32
High
$5.32
Low
$4.95
Mkt. cap
345.50M
Avg. vol.
294.14K
Volume
287.80K
52-wk high
$5.44
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
News stories
From web sources and news partners
Trefis
·
4 hours ago
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
qz.com
·
14 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
Reuters
·
22 hours ago
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
Traders Union
·
21 hours ago
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc